News Room

Prescient thought leaders are available to comment on a variety of healthcare and industry-related topics. For more information or to connect to a subject matter expert or thought leader, please contact info@prescienthg.com.
In the News

Prescient Healthcare Group Strengthens Its US Leadership Team

Posted on 07/16/2018

Prescient appoints Dr. Paul Harney as President, North America. LONDON, July 17, 2018—Prescient Healthcare Group, a biopharmaceutical product and portfolio strategy firm, announces the recent appointment of Dr. Paul Harney as President, North America. He has also been named to Prescient’s Board of Directors. Paul joins Prescient after spending more than 20 years providing [...] Read More

 

Twitter Feed

Prescient’s Dr. Mark Little will be attending FierceBiotech’s Drug Development Forum in Boston, October 28-29, featuring insights from C-suite and executive leadership at biotech, mid-sized and large pharma companies https://t.co/GQmWe0Ek9t

2019 ASBMR Young Investigator Award

Prescient’s Andrea Campi has been recognized with the ASBMR Young Investigator Award.

2019 Pharma CiMi.CON USA

The 2019 annual Pharma CiMi.CON will be held on November 7-8 in Boston. Dr. Mark Little will attend this event on behalf of Prescient. The event will bring together more than 120 competitive and market intelligence professionals for networking and exchange, to discuss key industry topics and to create new partnerships.

2019 New Product Planning (NPP) Summit

Prescient will be in Boston, MA, for the 2019 New Product Planning Summit on December 2-3, 2019.

Biocom Q4 2019 Deal Makers Reception

The Biocom Q4 2019 Deal Makers Reception Awards will be held on Thursday, December 12, in La Jolla, California. Biocom is an exclusive networking group made up of representatives from the biotech space, academia, research institutions and venture capital firms who are interested in discussing key trends and news with other industry leaders. Dr. Paul Harney and Dr. Debasish Talukdar will attend the event on behalf of Prescient.

2019 FierceBiotech Drug Development Forum

The 2019 FierceBiotech Drug Development Forum will be held on October 28-29, 2019, in Boston. Dr. Mark Little will attend the event on behalf of Prescient. The event will feature insights from C-suite and executive leadership at biotech, mid-sized and large pharma companies addressing the strategic and operational challenges in product development strategy and deal-making and business strategy.

Manuscript: A novel secreted-cAMP pathway inhibits pulmonary hypertension via a feed-forward mechanism

The European Society of Cardiology has accepted and published a manuscript from Prescient's Carly Jones in Cardiovascular Research:

2019 Annual PhD to Consulting Conference

The 2019 Annual Ph.D. to Consulting (PTC) Conference will be held on September 20, 2019, in London. The conference is a one-day annual event targeted at doctoral and post-doctoral researchers interested in pursuing a career in consulting. It provides a platform for discussion and networking for Ph.D. researchers and professionals from top consulting firms.

2019 Baird Global Healthcare Conference

The 2019 Baird Global Healthcare Conference will be held on September 4-5, 2019, in New York. Dr. Paul Harney and Dr. Mark Little will attend the event on behalf of Prescient. Executives from more than 90 small- to mid-sized companies will be in attendance discussing how they create value in their respective markets.

ISBM’s Driving Marketing Excellence and Strategic Insights for B2B – 2019

The Institute for the Study of Business Markets (ISBM)'s Driving Marketing Excellence and Strategic Insights for B2B event will be held on September 25-26, 2019, in Pittsburgh, PA. Dr. Mark Little will present "From Intelligence to Insights in a Competitive B2B" during a roundtable session on Thursday, September 26.

2019 Pharma CI USA Conference

Prescient will be in Newark, NJ, for the 2019 Pharma CI USA Conference and Exhibition on September 18-19, 2019.